THE PROBLEMS SPECIAL T0 CANCER PAIN MANAGEMENT
Al-Gohary moussa Tantawy;
Abstract
Cancer pam management is still inadequate. It is mandatory to get rid of the causes of such inadequacy to improve pain management in cancer patients. Opioids constitute the mainstay of pharmacologic therapy of cancer pain. However, opioid use has its problems; especially in cancer patient. These problems include:
• modulation of the immune system and thus affection the rate of tumor growth,
• development of tolerance and dependence and thus limiting the usefulness of opioids; and
• emergence of opioid neurotoxicity.
Recently, approaches have been developed to reduce (or prevent at all) such problems e.g. using opioid immunopotentiators, using NMDA Antagonists to reduce tolerance and avoiding the risk factors responsible for opioid neurotoxicity.
• modulation of the immune system and thus affection the rate of tumor growth,
• development of tolerance and dependence and thus limiting the usefulness of opioids; and
• emergence of opioid neurotoxicity.
Recently, approaches have been developed to reduce (or prevent at all) such problems e.g. using opioid immunopotentiators, using NMDA Antagonists to reduce tolerance and avoiding the risk factors responsible for opioid neurotoxicity.
Other data
| Title | THE PROBLEMS SPECIAL T0 CANCER PAIN MANAGEMENT | Other Titles | المشاكل الخاصة بالآلام السرطانية وعلاجها | Authors | Al-Gohary moussa Tantawy | Keywords | Addiction, Cancer Pain, Dependence, Glutamate Receptors, NMDA Receptors, Non Opioid Analgesics, Opioids, Pain Assessment Pain Measurement | Issue Date | 2000 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.